A Single-center, Randomized, Double-blind, Two-period Crossover Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Balovaptan (Primary) ; Risperidone (Primary)
- Indications Autistic disorder
- Focus Pharmacokinetics
- Sponsors Roche
- 18 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Nov 2012 New trial record
- 01 Nov 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.